AQR Capital Management
NUVB icon

AQR Capital Management’s Nuvation Bio NUVB Stock Holding History

AQR Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.56M Buy
1,995,758
+326,592
+20% +$1.82M ﹤0.01% 1422
2025
Q4 		$15M Sell
1,669,166
-365,045
-18% -$2.26M 0.01% 1046
2025
Q3 		$7.53M Buy
2,034,211
+896,919
+79% +$2.44M ﹤0.01% 1224
2025
Q2 		$2.22M Buy
1,137,292
+1,001,883
+740% +$2.09M ﹤0.01% 1716
2025
Q1 		$238K Sell
135,409
-685,950
-84% -$1.56M ﹤0.01% 2795
2024
Q4 		$2.18M Buy
821,359
+78,922
+11% +$203K ﹤0.01% 1491
2024
Q3 		$1.7M Buy
742,437
+630,854
+565% +$1.92M ﹤0.01% 1577
2024
Q2 		$326K Buy
111,583
+93,233
+508% +$284K ﹤0.01% 2234
2024
Q1 		$66.8K Buy
+18,350
New +$35.2K ﹤0.01% 2366

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management's NUVB Position: Q1 2026 in Review

AQR Capital Management increased its Nuvation Bio (NUVB) stake by 20% in Q1 2026, buying an estimated $1.82M and bringing the position to 1,995,758 shares worth $8.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

AQR Capital Management first reported a position in NUVB in Q1 2024 and has held it in 9 quarters since. The position peaked at $15M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • AQR Capital Management held 1,995,758 shares of Nuvation Bio worth $8.56M as of Q1 2026.
  • AQR Capital Management bought 326,592 Nuvation Bio shares in Q1 2026, an estimated $1.82M.
  • Nuvation Bio made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1422 holding.
  • AQR Capital Management first reported a position in Nuvation Bio in Q1 2024 and has held it in 9 quarters since.
  • AQR Capital Management's Nuvation Bio position peaked at $15M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.